Unknown

Dataset Information

0

Changes in heart rate variability during vasomotor symptoms among midlife women.


ABSTRACT: Most midlife women report vasomotor symptoms (VMS), yet their physiology remains poorly understood. This study tested whether acute decreases in cardiac vagal control would occur with VMS in a large sample of women monitored during wake and sleep.Two hundred and fifteen nonsmoking women aged 40 to 60 years with evidence of VMS were included. Women were free of a history of clinical cardiovascular disease or arrhythmia; or use of insulin, beta blockers, calcium channel blockers, or medications impacting VMS. Women underwent 24?hours of ambulatory monitoring for physiological (sternal skin conductance) and self-report (electronic diary) measurement of VMS; heart rate variability (electrocardiogram); and respiratory rate. Changes in cardiac vagal control as assessed by respiratory sinus arrhythmia during VMS, relative to periods before and after VMS, were tested in linear mixed models.Significant decreases in respiratory sinus arrhythmia were observed during physiologically measured VMS relative to periods preceding (b[SE]?=?0.13 (0.004), P?

SUBMITTER: Thurston RC 

PROVIDER: S-EPMC4844776 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Changes in heart rate variability during vasomotor symptoms among midlife women.

Thurston Rebecca C RC   Matthews Karen A KA   Chang Yuefang Y   Santoro Nanette N   Barinas-Mitchell Emma E   von Känel Roland R   Landsittel Doug P DP   Jennings J Richard JR  

Menopause (New York, N.Y.) 20160501 5


<h4>Objective</h4>Most midlife women report vasomotor symptoms (VMS), yet their physiology remains poorly understood. This study tested whether acute decreases in cardiac vagal control would occur with VMS in a large sample of women monitored during wake and sleep.<h4>Methods</h4>Two hundred and fifteen nonsmoking women aged 40 to 60 years with evidence of VMS were included. Women were free of a history of clinical cardiovascular disease or arrhythmia; or use of insulin, beta blockers, calcium c  ...[more]

Similar Datasets

| S-EPMC4742392 | biostudies-literature
| S-EPMC4893767 | biostudies-literature
| S-EPMC8277115 | biostudies-literature
| S-EPMC7987172 | biostudies-literature
| S-EPMC8208832 | biostudies-literature
| S-EPMC7685289 | biostudies-literature
| S-EPMC3551537 | biostudies-literature
| S-EPMC3298675 | biostudies-literature
| 2364606 | ecrin-mdr-crc
| S-EPMC4762229 | biostudies-literature